Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Dr. Cobuzzi served as a non-employee director and member of the Compensation and Nominating and Governance Committees until his appointment as Chief Executive Officer in September 2020. Summary Director Compensation Table for Fiscal 2020 shows total compensation of $817,495. |
| 2022-02-28 | On behalf of the Board of Directors and management of Diffusion Pharmaceuticals Inc., it is my pleasure to express our appreciation for your support. Sincerely, /s/ Robert J. Cobuzzi, Jr. Robert J. Cobuzzi, Jr. President and Chief Executive Officer |
| 2022-03-28 | Robert J. Cobuzzi, Jr. President and Chief Executive Officer Also holds Series C Preferred Stock and common stock options. |
| 2024-04-29 | Robert J. Cobuzzi, Jr., Ph.D., has served as our Chief Operating Officer since August 2023 and as a director since November 2023. Dr. Cobuzzi previously served as Diffusion’s President and Chief Executive Officer from September 2020 to August 2023. |
Data sourced from SEC filings. Last updated: 2026-03-05